EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Tremors and Health-Related Quality of Life in Liver Transplant Recipients: Post-hoc Analysis of a Multicenter, Randomized, Controlled Trial Comparing a Life Cycle Pharma-Tacrolimus Regimen and Extended-Release Tacrolimus Regimen

M B Mulder, J J Busschbach, B van Hoek, W G Polak, I P J Alwayn, B C M de Winter, S Darwish Murad, E Verhey-Hart, L Elshove, N S Erler, D A Hesselink, C M den Hoed und 1 weitere

Transplant International · 2025

DOI: 10.3389/ti.2025.14189 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Transplant International, 2025. Verfasst von M B Mulder und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands. Hauptthemen laut MEDLINE: Tacrolimus, Quality of Life, Liver Transplantation, Immunosuppressive Agents. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chiesi Farmaceutici.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We investigated whether life cycle pharma (LCP)-tacrolimus compared to extended-release (ER)-tacrolimus results in a difference in severity of tremors and HRQoL. In this multi-center, open-label, randomized, controlled trial, 108 patients were randomized in a 1:1 ratio to either LCP-tacrolimus regimen or ER-tacrolimus regimen after transplantation. HRQoL was assessed with the EQ-5D-5L and SF-36 questionnaire (two generic HRQoL instruments) and the quality of life in essential tremor (QUEST) questionnaire (domain specific HRQoL instrument). The EQ-5D-5L scores were translated to the societal values. We examined the HRQoL over the course of the study by fitting generalized mixed effect models. In total, 105 patients were included, 53 to the LCP- and 52 to the ER-tacrolimus regimen. Baseline questionnaires were available for every LT recipient. At 12 months 25% [10/40], 95% confidence interval (CI) 14.2%–40.2% of the LT recipients in the LCP-tacrolimus regimen group experienced tremors compared to 30.4% [14/46], 95%-CI 19.1%–44.8% of the LT recipients in the ER-tacrolimus regimen group; risk difference: 0.054; 95%-CI −0.151–0.249; p = 0.63. No statistically significant differences in HRQoL were seen between the two regimens. We could not demonstrate differences in the HRQoL or occurrence of tremors between LCP-tacrolimus and ER-tacrolimus regimens

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusQuality of LifeLiver TransplantationImmunosuppressive AgentsTremorHumansMaleFemaleMiddle AgedDelayed-Action PreparationsAgedSurveys and QuestionnairesAdult

Stichwörter der Autor:innen

healthrelated quality of lifeimmunosuppressive therapyliver transplantationtacrolimustremors

Substanzen

TacrolimusImmunosuppressive AgentsDelayed-Action Preparations

Autor:innen und Institutionen

  • Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Erasmus MC Transplant Institute, Rotterdam, Netherlands.
  • Section of Medical Psychology and Psychotherapy, Department of Psychiatry, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Department of Gastroenterology and Hepatology, LUMC, Leiden University Medical Center, Leiden, Netherlands.
  • Department of Surgery, Division of HPB and Transplant Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Department of Surgery, LUMC, Leiden University Medical Center, Leiden, Netherlands.

Förderung

  • Chiesi Farmaceutici

Zitieren

APA

Mulder, M. B., Busschbach, J. J., van Hoek, B., Polak, W. G., Alwayn, I. P. J., de Winter, B. C. M., Murad, S. D., Verhey-Hart, E., Elshove, L., Erler, N. S., Hesselink, D. A., den Hoed, C. M., & Metselaar, H. J. (2025). Tremors and Health-Related Quality of Life in Liver Transplant Recipients: Post-hoc Analysis of a Multicenter, Randomized, Controlled Trial Comparing a Life Cycle Pharma-Tacrolimus Regimen and Extended-Release Tacrolimus Regimen. Transplant International. https://doi.org/10.3389/ti.2025.14189

Vancouver

Mulder MB, Busschbach JJ, van Hoek B, Polak WG, Alwayn IPJ, de Winter BCM, et al. Tremors and Health-Related Quality of Life in Liver Transplant Recipients: Post-hoc Analysis of a Multicenter, Randomized, Controlled Trial Comparing a Life Cycle Pharma-Tacrolimus Regimen and Extended-Release Tacrolimus Regimen. Transplant International. 2025. doi:10.3389/ti.2025.14189

BibTeX
@article{Mulder2025,
  author = {Mulder, M B and Busschbach, J J and van Hoek, B and Polak, W G and Alwayn, I P J and de Winter, B C M and Murad, S Darwish and Verhey-Hart, E and Elshove, L and Erler, N S and Hesselink, D A and den Hoed, C M and Metselaar, H J},
  title = {Tremors and Health-Related Quality of Life in Liver Transplant Recipients: Post-hoc Analysis of a Multicenter, Randomized, Controlled Trial Comparing a Life Cycle Pharma-Tacrolimus Regimen and Extended-Release Tacrolimus Regimen},
  journal = {Transplant International},
  year = {2025},
  doi = {10.3389/ti.2025.14189}
}
Kostenlos starten →